Table of contents
March 2006 Volume 3 No 3
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
Efaproxiral is an effective addition to WBRT in patients with brain metastases
116Vessel-related variables improve prognostic ability of the Dukes staging system
116Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
116Intraperitoneal chemotherapy for ovarian cancer: challenges and future directions
117Does concurrent exemestane affect tamoxifen pharmacokinetics?
117Improved definitions of biochemical failure in prostate cancer patients
118Occult gynecologic malignancies in BRCA1 and BRCA2 mutation carriers
118Plasma exchange does not ameliorate myeloma-induced acute renal failure
119Use of SU11248 to inhibit proangiogenic growth factors in renal-cell carcinoma patients
119Treatment of malignant glioma with high-dose conformal radiotherapy
120No association between dietary-fiber intake and colorectal cancer
120Transdermal fentanyl for managing chronic pain in children
121Reducing the gynecomastia and breast pain associated with bicalutamide therapy
121Downstaging of hepatocellular carcinoma before transplantation
122Long-term steroids might not increase lymphoma risk for some patients
122Top of page
Practice Points
Preoperative radiotherapy for rectal cancer: beyond local control
124Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials?
126Is intraoperative lymphatic mapping and sentinel lymph node biopsy effective and safe in early-stage melanoma?
128Should prophylactic antibiotics be used in afebrile neutropenic oncology patients?
130What is the incidence of stroke in survivors of childhood Hodgkin's disease?
132Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?
134Top of page
Reviews
Mechanisms of Disease: breast tumor pathogenesis and the role of the myoepithelial cell
138doi:10.1038/ncponc0450 | Full Text | PDF (1,732K)
Cancer-related anemia and recombinant human erythropoietin—an updated overview
152doi:10.1038/ncponc0451 | Full Text | PDF (245K)
Top of page
Case Study
Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab
165doi:10.1038/ncponc0430 | Full Text | PDF (120K)
